Fritextsökning
Artiklar per år
Innehållstyper
-
Hey Kurt Berndt...
... who is starting up a research center for youths in Saltsjöbaden.
-
Gel i rumstemperatur - vätska i kylrummet
Biostatus presenterar en fixeringsgel för användning vid fotografering som blir vätska i kylskåpstemperatur och gel i rumstemperatur.
-
Nytt cellavbildningssystem från GE Healthcare
GE Healthcare lanserar IN Cell Analyzer 2000, ett tillskott till forskningsfältet för höginformativ analys, som kan användas för att ta digitala fotografier av både objektglas och cellodlingsplattor.
-
Lina Medical expanderar i väst
Det danska medicinteknikbolaget ska etablera en egen säljorganisation i USA, och planerar att stort antal nyrekryteringar.
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at approximately $68 billion. The Boards of Directors of both companies have said yes to the deal that may lead to lay-offs of some 8,000 persons.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
New NO product reduces diabetic pain
The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
New map of eye proteins
A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
BREAKING